Barinthus Biotherapeutics plc
BRNS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61,183 | -$73,447 | $5,321 | -$51,112 |
| Dep. & Amort. | $5,800 | $5,429 | $4,323 | $602 |
| Deferred Tax | -$44 | -$3,075 | -$4,337 | -$119 |
| Stock-Based Comp. | $4,709 | $5,055 | $9,877 | $16,487 |
| Change in WC | $2,601 | $6,171 | -$5,524 | -$7,178 |
| Other Non-Cash | $19,177 | $8,942 | -$24,091 | $8,737 |
| Operating Cash Flow | -$28,940 | -$50,925 | -$14,431 | -$32,583 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$892 | -$5,413 | -$6,138 | -$1,146 |
| Net Acquisitions | $0 | $0 | $0 | -$11,766 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $388 | $0 |
| Investing Cash Flow | -$892 | -$5,413 | -$5,750 | -$12,912 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$159 | $0 |
| Stock Issued | $2,163 | $2,035 | $484 | $102,774 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$163 | $0 | $119,968 |
| Financing Cash Flow | $2,163 | $1,872 | $325 | $222,742 |
| Forex Effect | -$2,021 | $2,171 | $187 | -$6,459 |
| Net Chg. in Cash | -$29,690 | -$52,295 | -$19,669 | $170,788 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $142,090 | $194,385 | $214,054 | $43,266 |
| End Cash | $112,400 | $142,090 | $194,385 | $214,054 |
| Free Cash Flow | -$29,832 | -$56,338 | -$20,569 | -$33,729 |